Advertisement

I Get By With a Little Help From the 19th Century

The last time I visited Ralph Waldo Emerson’s and Walt Whitman’s writings with anything close to serious study was back in college, over a decade ago. In the intervening years, I’ve read through Emerson’s "Self-Reliance" a few times and paged through Whitman’s "Song of Myself" every few years, often reading the poem aloud for its music. Therefore, due to my neglect and the time since I’ve studied it, you’ll forgive me for possibly bastardizing American Transcendentalism when I quote both authors in this week’s entry. Read More “I Get By With a Little Help From the 19th Century”

Ode to Diabetes, or Oh Diabetes

Maybe it’s the season, or that this is Eric’s last blog entry of 2007, but whatever it is, he’s pushed his prose into line breaks this week. So without much further ado, here’s Eric’s poem to close out his first year as someone with Type 1 diabetes. If any of the details of the poem make you say “What?” don’t worry; you may want to reference his first few blog entries from back in July, though. And Eric says that you needn’t worry—he won’t continue the poetic blog entries in 2008. Read More “Ode to Diabetes, or Oh Diabetes”

Jan Cleans Out Files, Comes Up With Blog Entry

I have a "temp" folder inside my "DSM Blog" folder on my computer. When I run across something that looks interesting, I put it in there. Another folder is labeled "pending," which is where I jot down ideas. Sometimes I can’t immediately figure out what to do with those ideas—or something else comes along.

Judging from the snow and ice outside my window, it isn’t spring yet, but it’s as good a time as any to do some cleaning.

Read More “Jan Cleans Out Files, Comes Up With Blog Entry”

Study Finds New Risks for Avandia

A new study of an older, "real-world" population, published in the December 12 issue of The Journal of the American Medical Association (JAMA), has confirmed the findings of earlier research by linking Type 2 diabetes drug rosiglitazone (brand name Avandia) with increased heart risks. It has also uncovered a new risk associated with the drug—namely, an increased risk of dying that had not been observed before. Studies of rosiglitazone have made the news a lot lately (see our own recent coverage in "Avandia: New Warning and Findings"). Read More “Study Finds New Risks for Avandia”

Get Diabetes-Friendly Recipes In Your Inbox

Sign up for Free

Stay Up To Date On News & Advice For Diabetes

Sign up for Free

Get On Track With Daily Lifestyle Tips

Sign up for Free

Save Your Favorites